| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Matinas BioPharma Holdings, Inc.
13D/A
Amendment 2
MTNB · 576810303
|
10.0% |
8/13/2026
Event 6/10/2026
|
|||
| Sanitam Partners LLC | 0% | ||||
| Stern Adam K | 10.0% | ||||
|
Matinas BioPharma Holdings, Inc.
13D/A
Amendment 1
MTNB · 576810303
|
10.0% |
4/10/2025
Event 4/8/2025
|
|||
| Sanitam Partners LLC | 10.0% | ||||
| Stern Adam K | 10.0% | ||||
| HEZBAY Holdings LLC | 10.0% | ||||
| Ari Kluger | 10.0% | ||||
| Platinum Point Capital, LLC | 10.0% | ||||
| Brian Freifeld | 10.0% | ||||
|
Matinas BioPharma Holdings, Inc.
13D
MTNB · 576810303
|
24.1% |
2/21/2025
Event 2/13/2025
|
|||
| Sanitam Partners LLC | 20.0% | ||||
| Stern Adam K | 24.1% | ||||
| HEZBAY Holdings LLC | 20.0% | ||||
| Ari Kluger | 20.0% | ||||
| Platinum Point Capital, LLC | 20.0% | ||||
| Brian Freifeld | 20.0% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.